Crewe Advisors LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1730033
SALT LAKE CITY, UT
Position in CRL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,442
-$4,473 QoQ
Shares Held
24
-50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#495
of 564 holders
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $857,580 across 13 Diagnostics & Research names. CRL ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
926 | $464,259 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
|
2,886 | $247,597 | |
| 3 | DHR |
Danaher Corp /De/
|
418 | $79,620 | |
| 4 | GRAL |
GRAIL, Inc.
|
379 | $25,874 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
54 | $10,433 | |
| 6 | A |
Agilent Technologies, Inc.
|
60 | $7,969 | |
| 7 | WAT |
Waters Corp /De/
|
18 | $6,750 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
This page
|
24 | $5,442 |
All Filings in CRL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,442 | 24 | Shares | Sole | 2026-07-24 | |
| 2024-06-30 | $9,915 | 48 | Shares | Sole | 2024-07-29 | |
| 2022-09-30 | $5,510 | 28 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,991 | 28 | Shares | Sole | 2022-08-02 | |
| No filing history on record for this holder in this stock. | ||||||